San Francisco, Aug. 30, 2016 — Recardio today announced that it has raised $11 million in an increased Series A Financing.Read More
Recardio Names Darrell Nix as Chief Scientific Officer
San Francisco, Mar. 08, 2016 – Recardio named Darrell Nix as Chief Scientific Officer.Read More
Recardio to Present at Biotech Showcase 2016 during JP Morgan
San Francisco, Jan. 08, 2016 — Recardio to present at Biotech Showcase 2016 on January 11, 2016 at 2:00 p.m. PST during JP Morgan in San Francisco.Read More